Evidence map›Paper›PMID 32520911›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

The Cascade of Care From Routine Point-of-Care HIV Testing at Birth: Results From an 18-Months Pilot Program in Eswatini.

Philisiwe Ntombenhle Khumalo, Emma Sacks, Caspian Chouraya, Bhekisisa Tsabedze, Thembie Masuku, Gcinile Nyoni, Tandzile Zikalala, Bonisile Nhlabatsi, Nobuhle Mthethwa, Jennifer Cohn

Open access · hybridAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Philisiwe Ntombenhle KhumaloResearch and Public Health Evaluation, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Emma SacksDepartment of Global Health, Milken Institute School of Public Health, The George Washington University, Washington, DC.
Caspian ChourayaExecutive Leadership & Senior Management Teams, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Bhekisisa TsabedzeResearch and Public Health Evaluation, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Thembie MasukuInnovations/Unitaid, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Gcinile NyoniInnovations/Unitaid, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Tandzile ZikalalaInnovations/Unitaid, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Bonisile NhlabatsiEswatini National AIDS Program, Ministry of Health, Mbabane, Eswatini.
Nobuhle MthethwaSexual Reproductive Heath Unit, Ministry of Health, Mbabane, Eswatini; and.
Jennifer CohnInnovation and New Technology, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC.
Elizabeth Glaser Pediatric AIDS Foundation · USMinistry of Health · SZMilken Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV testing at birth may improve early treatment, but concerns remain about feasibility and retention of infants in care. In 2017, point-of-care (POC) HIV birth testing was introduced into routine care at 3 high-volume maternity health facilities in Eswatini.

methodsPOC birth testing was offered to HIV-exposed infants (HEI) born at, or presenting to, 3 maternities within 3 days of birth. Data were collected from a project-specific EID test request form and routine registers on all tests conducted from August 1, 2017 to November 30, 2018, including retesting at 6-8 weeks for infants testing negative at birth and six-month retention in HIV care and viral load suppression among infants testing HIV-positive at birth.

resultsOf 4322 eligible HEI, 3311 (76.6%) were tested. Twenty-six HIV-infected infants were identified (positivity rate 0.8%) and 25 initiated on antiretroviral therapy (ART) (96.1%). The median time from sample collection to ART initiation was 20.50 days (IQR 14-45). Twenty-one (84%) ART-initiated infants were on ART at 6 months after initiation. Nineteen infants (90.5%) had viral load test information at 6 months and 16 (84.2%) were virally suppressed. Of 3126 HEI testing negative at birth, 3004 (96.1%) were linked to laboratory databases and 2744 (91.3%) were retested at 6-8 weeks, with 9 (0.3%) additional infants testing HIV-positive.

conclusionsUptake of POC birth testing was high in Eswatini with low HIV positivity. Almost all infants identified HIV-positive at birth were initiated on ART, with high retention in care and viral suppression. Birth testing did not seem to significantly reduce subsequent 6-8-week testing.

Indexed as

Point-of-Care TestingAnti-HIV AgentsEswatiniFemaleHIV InfectionsHIV TestingHumansInfant, NewbornInfant, Newborn, DiseasesMalePilot ProjectsViral LoadAnti-HIV Agents

Identifiers

PMID32520911
PMCPMC7302329
OpenAlexW3033120169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.